Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia NCT00004128 Leukemia
aldesleukin
filgrastim
busulfan
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
autologous bone...
peripheral bloo...
radiation thera...
15 Years - 60 Years National Cancer Institute (NCI) View Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission NCT00070135 Adult Acute Mye...
Acute Myeloid L...
filgrastim
Anti-Thymocyte ...
busulfan
fludarabine pho...
methotrexate
tacrolimus
Allogeneic Hema...
60 Years - 74 Years Alliance for Clinical Trials in Oncology View Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 NCT01407757 Leukemia
DNA analysis
gene expression...
laboratory biom...
pharmacogenomic...
- 29 Years Children's Oncology Group View Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia NCT00089050 Leukemia
cyclosporine
gemtuzumab ozog...
60 Years - Fred Hutchinson Cancer Center View Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia NCT00818649 Leukemia
Myelodysplastic...
bortezomib
vorinostat
18 Years - Masonic Cancer Center, University of Minnesota View Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia NCT00101231 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Recurrent Adult...
Relapsing Chron...
alvocidib
1 Year - National Cancer Institute (NCI) View Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia NCT00002588 Leukemia
etoposide
topotecan hydro...
18 Years - Case Comprehensive Cancer Center View Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia NCT00093483 Leukemia
filgrastim
arsenic trioxid...
cytarabine
idarubicin
18 Years - 59 Years Roswell Park Cancer Institute View S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00066794 Leukemia
filgrastim
sargramostim
cyclosporine
cytarabine
daunorubicin hy...
56 Years - SWOG Cancer Research Network View Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia NCT01159301 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Unspecified Adu...
entinostat
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia NCT00602771 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
tipifarnib
etoposide
70 Years - National Cancer Institute (NCI) View Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission NCT00002768 Leukemia
filgrastim
busulfan
cytarabine
etoposide
methotrexate
peripheral bloo...
15 Years - 69 Years Alliance for Clinical Trials in Oncology View S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00004217 Leukemia
filgrastim
sargramostim
cytarabine
daunorubicin hy...
valspodar
56 Years - SWOG Cancer Research Network View Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission NCT00101140 Adult Acute Ery...
Adult Acute Mon...
Adult Acute Mye...
anti-thymocyte ...
fludarabine pho...
thiotepa
biological ther...
bone marrow abl...
chemotherapy
non-specific im...
peripheral bloo...
radiation thera...
18 Years - 59 Years Eastern Cooperative Oncology Group View Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00003268 Drug/Agent Toxi...
Leukemia
amifostine trih...
cytarabine
idarubicin
18 Years - National Cancer Institute (NCI) View Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer NCT00003661 Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 Years Roswell Park Cancer Institute View S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia NCT01338974 Leukemia
gene expression...
proteomic profi...
flow cytometry
laboratory biom...
56 Years - SWOG Cancer Research Network View Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia NCT00003758 Leukemia
cytarabine
idarubicin
allogeneic bone...
autologous bone...
peripheral bloo...
15 Years - 60 Years National Cancer Institute (NCI) View Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia NCT00528398 Leukemia
cytarabine
idarubicin
16 Years - 60 Years City of Hope Medical Center View Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia NCT00004215 Anemia
Leukemia
Neutropenia
Thrombocytopeni...
filgrastim
leridistim
cytarabine
daunorubicin hy...
55 Years - Memorial Sloan Kettering Cancer Center View Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia NCT00006122 Leukemia
cytarabine
etoposide
gemtuzumab ozog...
idarubicin
mitoxantrone hy...
61 Years - European Organisation for Research and Treatment of Cancer - EORTC View Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT00634244 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
alvocidib
mitoxantrone hy...
carboplatin
cytarabine
sirolimus
etoposide
topotecan hydro...
18 Years - 65 Years National Cancer Institute (NCI) View Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00112853 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
tipifarnib
etoposide
70 Years - National Cancer Institute (NCI) View Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01349972 Acute Myeloid L...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
alvocidib
daunorubicin hy...
mitoxantrone hy...
cytarabine
18 Years - 70 Years National Cancer Institute (NCI) View Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy NCT01169363 Leukemia
proteomic profi...
flow cytometry
laboratory biom...
60 Years - 120 Years Eastern Cooperative Oncology Group View Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy NCT01235572 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Previously Trea...
Recurrent Adult...
standard follow...
medical chart r...
quality-of-life...
18 Years - 75 Years Fred Hutchinson Cancer Center View Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R NCT00534469 Leukemia
aldesleukin
filgrastim
busulfan
cytarabine
etoposide
idarubicin
autologous hema...
bone marrow tra...
peripheral bloo...
total-body irra...
16 Years - 60 Years City of Hope Medical Center View S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia NCT00899743 Leukemia
polyacrylamide ...
western blottin...
immunologic tec...
laboratory biom...
56 Years - SWOG Cancer Research Network View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00742625 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 Years National Cancer Institute (NCI) View VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia NCT00354276 Leukemia
cytarabine
laromustine
60 Years - National Cancer Institute (NCI) View Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00742625 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Untreated Adult...
daunorubicin hy...
cytarabine
bortezomib
60 Years - 75 Years National Cancer Institute (NCI) View Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia NCT00268229 Leukemia
cytarabine
daunorubicin hy...
imatinib mesyla...
18 Years - The Cleveland Clinic View Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes NCT00454480 Leukemia
Myelodysplastic...
alemtuzumab
arsenic trioxid...
azacitidine
busulfan
clofarabine
cytarabine
daunorubicin hy...
fludarabine pho...
gemtuzumab ozog...
melphalan
tipifarnib
DNA methylation...
cytogenetic ana...
gene expression...
mutation analys...
diagnostic labo...
immunologic tec...
allogeneic hema...
nonmyeloablativ...
- National Cancer Institute (NCI) View Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00651261 Leukemia
cytarabine
daunorubicin
midostaurin
placebo
dexamethasone a...
18 Years - 59 Years Alliance for Clinical Trials in Oncology View S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia NCT00899743 Leukemia
polyacrylamide ...
western blottin...
immunologic tec...
laboratory biom...
56 Years - SWOG Cancer Research Network View Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML NCT01849276 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Blastic Phase C...
Recurrent Adult...
Untreated Adult...
metformin hydro...
cytarabine
laboratory biom...
18 Years - Northwestern University View Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission NCT00045435 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
nonmyeloablativ...
fludarabine pho...
total-body irra...
cyclosporine
mycophenolate m...
peripheral bloo...
55 Years - Fred Hutchinson Cancer Center View Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia NCT00268242 Leukemia
Gemcitabine Hyd...
Mitoxantrone Hy...
18 Years - The Cleveland Clinic View Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia NCT01385150 Leukemia
mutation analys...
protein analysi...
laboratory biom...
liquid chromato...
mass spectromet...
17 Years - 60 Years Eastern Cooperative Oncology Group View Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia NCT00052299 Leukemia
cytarabine
etoposide
gemtuzumab ozog...
idarubicin
mitoxantrone hy...
61 Years - 75 Years European Organisation for Research and Treatment of Cancer - EORTC View Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Cellular Diagno...
Untreated Adult...
tipifarnib
laboratory biom...
65 Years - National Cancer Institute (NCI) View Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia NCT00352365 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
lenalidomide
60 Years - National Cancer Institute (NCI) View Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia NCT02144675 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Untreated Adult...
choline magnesi...
idarubicin
cytarabine
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer NCT00003661 Graft Versus Ho...
Leukemia
Lymphoma
Myelodysplastic...
Neuroblastoma
anti-thymocyte ...
busulfan
cyclosporine
melphalan
methylprednisol...
umbilical cord ...
radiation thera...
- 54 Years Roswell Park Cancer Institute View Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia NCT00528398 Leukemia
cytarabine
idarubicin
16 Years - 60 Years City of Hope Medical Center View Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia NCT02144675 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Untreated Adult...
choline magnesi...
idarubicin
cytarabine
laboratory biom...
18 Years - Rutgers, The State University of New Jersey View Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia NCT00005962 Leukemia
sargramostim
cyclophosphamid...
cytarabine
gemtuzumab ozog...
liposomal dauno...
topotecan hydro...
18 Years - 120 Years Eastern Cooperative Oncology Group View AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT01253447 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Akt inhibitor M...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia NCT00002658 Leukemia
Neutropenia
filgrastim
amsacrine
cyclophosphamid...
cytarabine
daunorubicin hy...
etoposide
idarubicin
mitoxantrone hy...
thioguanine
tretinoin
allogeneic bone...
autologous bone...
peripheral bloo...
radiation thera...
15 Years - National Cancer Institute (NCI) View Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia NCT00838240 Leukemia
Myelodysplastic...
clofarabine
cytarabine
idarubicin
18 Years - 60 Years European Organisation for Research and Treatment of Cancer - EORTC View Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission NCT00454168 Leukemia
PR1 leukemia pe...
sargramostim
placebo
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00006363 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Acute...
Childhood Myelo...
de Novo Myelody...
Untreated Adult...
Untreated Child...
cytarabine
daunorubicin hy...
etoposide
valspodar
filgrastim
busulfan
autologous hema...
peripheral bloo...
aldesleukin
clinical observ...
pharmacological...
15 Years - 59 Years National Cancer Institute (NCI) View Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia NCT00005962 Leukemia
sargramostim
cyclophosphamid...
cytarabine
gemtuzumab ozog...
liposomal dauno...
topotecan hydro...
18 Years - 120 Years Eastern Cooperative Oncology Group View Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R NCT00534469 Leukemia
aldesleukin
filgrastim
busulfan
cytarabine
etoposide
idarubicin
autologous hema...
bone marrow tra...
peripheral bloo...
total-body irra...
16 Years - 60 Years City of Hope Medical Center View Cilengitide in Treating Patients With Acute Myeloid Leukemia NCT00089388 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
cilengitide
50 Years - National Cancer Institute (NCI) View flt3L in Treating Patients With Acute Myeloid Leukemia NCT00006223 Leukemia
recombinant flt...
18 Years - National Cancer Institute (NCI) View Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia NCT01421875 Leukemia
DNA methylation...
RNA analysis
gene expression...
microarray anal...
nucleic acid se...
laboratory biom...
61 Years - 120 Years Eastern Cooperative Oncology Group View Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00814164 Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 Years Roswell Park Cancer Institute View Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy NCT01235572 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Previously Trea...
Recurrent Adult...
standard follow...
medical chart r...
quality-of-life...
18 Years - 75 Years Fred Hutchinson Cancer Center View Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy NCT02071901 Acute Myeloid L...
Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
eltrombopag ola...
60 Years - Case Comprehensive Cancer Center View Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia NCT00898456 Leukemia
gene expression...
molecular genet...
polymorphism an...
protein express...
diagnostic labo...
15 Years - Alliance for Clinical Trials in Oncology View Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT02085408 Acute Myeloid L...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Secondary Acute...
Untreated Adult...
Daunorubicin
Cytarabine
Clofarabine
Decitabine
Observation
Allogeneic hema...
60 Years - Eastern Cooperative Oncology Group View Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia NCT01127009 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
bortezomib
mitoxantrone hy...
etoposide
cytarabine
flow cytometry
18 Years - 70 Years Case Comprehensive Cancer Center View Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia NCT00131989 Adult Acute Bas...
Adult Acute Eos...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Recurrent Adult...
sorafenib tosyl...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Vorinostat in Treating Patients With Acute Myeloid Leukemia NCT00305773 Adult Acute Ery...
Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Pro...
Recurrent Adult...
Refractory Cyto...
Secondary Acute...
Untreated Adult...
vorinostat
vorinostat
18 Years - National Cancer Institute (NCI) View AML Therapy With Irradiated Allogeneic Cells NCT02105116 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
Untreated Adult...
fludarabine pho...
cytarabine
donor lymphocyt...
laboratory biom...
G-CSF
18 Years - Rutgers, The State University of New Jersey View S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML NCT00085709 Leukemia
gemtuzumab ozog...
observation
Cytosine arabin...
Daunomycin
18 Years - 60 Years SWOG Cancer Research Network View Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia NCT01251159 Leukemia
mutation analys...
polymerase chai...
immunologic tec...
laboratory biom...
16 Years - 60 Years Eastern Cooperative Oncology Group View Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT01904643 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
lenalidomide
mitoxantrone hy...
etoposide
cytarabine
18 Years - Stanford University View Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia NCT00053144 Leukemia
cytarabine
irinotecan hydr...
15 Years - Roswell Park Cancer Institute View Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia NCT00470197 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Malignant Neopl...
Recurrent Adult...
Recurrent Adult...
alvocidib
cytarabine
mitoxantrone hy...
pharmacological...
18 Years - National Cancer Institute (NCI) View Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy NCT00509093 Leukemia
imatinib mesyla...
gene expression...
mutation analys...
polymerase chai...
flow cytometry
biopsy
18 Years - Case Comprehensive Cancer Center View Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00651261 Leukemia
cytarabine
daunorubicin
midostaurin
placebo
dexamethasone a...
18 Years - 59 Years Alliance for Clinical Trials in Oncology View S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia NCT01575535 Leukemia
gene expression...
flow cytometry
fluorescence ac...
laboratory biom...
medical chart r...
18 Years - SWOG Cancer Research Network View Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia NCT00838240 Leukemia
Myelodysplastic...
clofarabine
cytarabine
idarubicin
18 Years - 60 Years European Organisation for Research and Treatment of Cancer - EORTC View High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia NCT00002945 Leukemia
aldesleukin
filgrastim
cyclophosphamid...
cytarabine
etoposide
idarubicin
melphalan
peripheral bloo...
radiation thera...
25 Years - Roswell Park Cancer Institute View Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia NCT00814164 Leukemia
clofarabine
daunorubicin hy...
cytogenetic ana...
protein express...
immunologic tec...
pharmacological...
60 Years - 120 Years Roswell Park Cancer Institute View Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT01835288 Adult Acute Meg...
Adult Acute Min...
Adult Acute Mon...
Adult Acute Mon...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Acute Mye...
Adult Erythrole...
Adult Pure Eryt...
Recurrent Adult...
arsenic trioxid...
laboratory biom...
18 Years - Stanford University View Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia NCT00006122 Leukemia
cytarabine
etoposide
gemtuzumab ozog...
idarubicin
mitoxantrone hy...
61 Years - European Organisation for Research and Treatment of Cancer - EORTC View